glp-1 and mash Novo's Wegovy becomes first drug approved for Incretin-based therapies in MASLD/MASH: from

doi:10.1111/jdi.13764

Journal of the American College of Nutrition, 34 (6), 478-487

Although the MDL process is currently very early, people diagnosed with NAION (sudden and mostly permanent vision loss) after taking Mounjaro now have a path forward to pursuing compensation

doi: 10.1016/J.AJOG.2024.08.024 88 GrahamDLMadkourHSNobleBLSchatschneiderCStanwoodGD

The fatty acid is key because it makes the drug bind more strongly to albumin in the blood, meaning it sticks around longer before getting cleared, DiMarchi says

High-intensity interval training (HIIT) has gained attention for metabolic benefits achieved in shorter durations